VeraDermics: Funding, Investors & Team (Oct 2026)
VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts. It offers a dissolvable microneedle patch solution that administers immunotherapy without any pain, a treatment that stimulates the body’s own immune system to fight off the wart virus. The patch is applied like a bandage and remains on the skin for less than an hour. During that time, the microneedles, which are composed of the immune stimulators in a sustained-release polymer matrix, dissolve from the adhesive backing and are implanted into the skin. The adhesive can then be removed, leaving the microneedles to dissolve in the skin over the next few weeks. During that time, immune stimulators are steadily released directly into the wart.
VeraDermics has raised $240M across 3 funding rounds on record, the most recent a Series C of $150M announced in Oct 2025.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
VeraDermics Company Profile and Key Stats
Latest funding round on record: Oct 2025.
VeraDermics Funding Rounds
VeraDermics raised $15.0M in an undisclosed round announced in May 2023.
1.6 years later, a Series B of $75.0M was announced in Dec 2024.
10 months later, a Series C of $150M was announced in Oct 2025.
VeraDermics Founders and Leadership Team
Contact details for the VeraDermics team: 1 of 3 have an email address on file.
Start 14-day free trial →VeraDermics Funding Compared to Other Health Care Startups
VeraDermics' latest round of $150M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like VeraDermics in Health Care and New Haven
Companies Similar to VeraDermics
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
VeraDermics Funding FAQs
What does VeraDermics do?
VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts. It offers a dissolvable microneedle patch solution that administers immunotherapy without any pain, a treatment that stimulates the body’s own immune system to fight off the wart virus. The patch is applied like a bandage and remains on the skin for less than an hour. During that time, the microneedles, which are composed of the immune stimulators in a sustained-release polymer matrix, dissolve from the adhesive backing and are implanted into the skin. The adhesive can then be removed, leaving the microneedles to dissolve in the skin over the next few weeks. During that time, immune stimulators are steadily released directly into the wart.
How much funding has VeraDermics raised?
VeraDermics has raised $240M across 3 rounds on record. The most recent is a Series C of $150M announced in Oct 2025.
When did VeraDermics last raise funding?
VeraDermics' most recent funding round on record is a Series C of $150M, announced in Oct 2025.
Who founded VeraDermics?
FundedIQ lists Lauren Durso (Founder), Ming Lee (Founder), Reid Waldman (Founder) at VeraDermics.
Where is VeraDermics headquartered?
VeraDermics is based in New Haven, Connecticut, United States.
How many employees does VeraDermics have?
VeraDermics is in the 1-10 employee band.
How does VeraDermics' funding compare to other Health Care startups?
VeraDermics' latest round of $150M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's VeraDermics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VeraDermics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.